Revolution’s Rasonque off to best cancer drug launch ‘in history’

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 05 Nov, 16:21 UTC

Wall Street analysts are already resetting projections for Rasonque — but company executives cautioned that it’s too early to draw conclusions about the pancreatic cancer drug’s launch trajectory.

science

Sources

• T2Revolution’s Rasonque off to best cancer drug launch ‘in history’BioPharma Dive / Healthcare Dive / MedTech Dive05 Nov, 16:21